BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20648927)

  • 1. In vitro studies of ferric carboxymaltose on placental permeability using the dual perfusion model of human placenta.
    Malek A
    Arzneimittelforschung; 2010; 60(6a):354-61. PubMed ID: 20648927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of transferrin in iron transport between maternal and fetal circulations of a perfused lobule of human placenta.
    Contractor SF; Eaton BM
    Cell Biochem Funct; 1986 Jan; 4(1):69-74. PubMed ID: 3943149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the magnesium aspartate hydrochloride administration to the maternal circuit on the aspartate concentration of the fetal circuit under in vitro perfusion of human placenta.
    Malek A; Leiser R
    Eur J Obstet Gynecol Reprod Biol; 2009 Jan; 142(1):12-7. PubMed ID: 18951687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.
    Geisser P; Banké-Bochita J
    Arzneimittelforschung; 2010; 60(6a):362-72. PubMed ID: 20648928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The new generation of intravenous iron: chemistry, pharmacology, and toxicology of ferric carboxymaltose.
    Funk F; Ryle P; Canclini C; Neiser S; Geisser P
    Arzneimittelforschung; 2010; 60(6a):345-53. PubMed ID: 20648926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder.
    Geisser P; Rumyantsev V
    Arzneimittelforschung; 2010; 60(6a):373-85. PubMed ID: 20648929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human placental transport of oxytocin.
    Malek A; Blann E; Mattison DR
    J Matern Fetal Med; 1996; 5(5):245-55. PubMed ID: 8930795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic analysis of the transport of salicylic acid, a nonsteroidal anti-inflammatory drug, across human placenta.
    Shintaku K; Arima Y; Dan Y; Takeda T; Kogushi K; Tsujimoto M; Nagata H; Satoh S; Tsukimori K; Nakano H; Hori S; Ohtani H; Sawada Y
    Drug Metab Dispos; 2007 May; 35(5):772-8. PubMed ID: 17312018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theophylline transfer across human placental cotyledon during in vitro dual perfusion.
    Omarini D; Barzago MM; Aramayona J; Bortolotti A; Lucchini G; Bonati M
    J Med; 1992; 23(2):101-16. PubMed ID: 1512518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplacental pharmacokinetics of diclofenac in perfused human placenta.
    Shintaku K; Hori S; Tsujimoto M; Nagata H; Satoh S; Tsukimori K; Nakano H; Fujii T; Taketani Y; Ohtani H; Sawada Y
    Drug Metab Dispos; 2009 May; 37(5):962-8. PubMed ID: 19204082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial.
    Allen RP; Adler CH; Du W; Butcher A; Bregman DB; Earley CJ
    Sleep Med; 2011 Oct; 12(9):906-13. PubMed ID: 21978726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications.
    Bailie GR
    Arzneimittelforschung; 2010; 60(6a):386-98. PubMed ID: 20648930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron sucrose and ferric carboxymaltose: no correlation between physicochemical stability and biological activity.
    Praschberger M; Haider K; Cornelius C; Schitegg M; Sturm B; Goldenberg H; Scheiber-Mojdehkar B
    Biometals; 2015 Feb; 28(1):35-50. PubMed ID: 25326244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and toxicity studies of AZT (zidovudine) following perfusion of human term placenta for 14 hours.
    Boal JH; Plessinger MA; van den Reydt C; Miller RK
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):13-21. PubMed ID: 9073587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permeability of human placenta and fetal membranes to thyrotropin-stimulating hormone in vitro.
    Bajoria R; Fisk NM
    Pediatr Res; 1998 May; 43(5):621-8. PubMed ID: 9585008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mechanisms involved in iron transfer across the isolated guinea pig placenta by means of bolus experiments.
    van Dijk JP; van Kreel BK; Heeren JW
    J Dev Physiol; 1985 Feb; 7(1):1-16. PubMed ID: 3980923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic studies of enalaprilat in the in vitro perfused human placental lobule system.
    Miller RK; Jessee L; Barrish A; Gilbert J; Manson JM
    Teratology; 1998; 58(3-4):76-81. PubMed ID: 9802186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein transport across the in vitro perfused human placenta.
    Malek A; Sager R; Lang AB; Schneider H
    Am J Reprod Immunol; 1997 Oct; 38(4):263-71. PubMed ID: 9352013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo evidence for the functional heterogeneity of transferrin-bound iron. II. Studies in pregnant rats.
    Awai M; Chipman B; Brown EB
    J Lab Clin Med; 1975 May; 85(5):785-96. PubMed ID: 1123559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual messenger function for prostaglandin E2 (PGE2) in human placenta.
    Sastry BV; Hemontolor ME; Chance MB; Johnson RF
    Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):417-24. PubMed ID: 9193797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.